The presence of the blood–brain barrier (BBB) presents the most critical challenge in therapeutic development for mucopolysaccharidosis (MPS) IIIB, a lysosomal storage disease with severe neurological ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback